Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.570
+0.220 (5.06%)
At close: Jun 26, 2026, 4:00 PM EDT
4.550
-0.020 (-0.44%)
Pre-market: Jun 29, 2026, 6:43 AM EDT
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $24.7 million as of June 29, 2026. Its market cap has increased by 83.75% in one year.
Market Cap
24.70M
Enterprise Value
5.29M
1-Year Change
83.75%
Ranking
Category
Stock Price
$4.57
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $24.70M, an increase of 128.93%. That is a compound annual growth rate of 73.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 24.70M | 18.38% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Serina Therapeutics | 27.15M |
| NeuroSense Therapeutics | 26.77M |
| BriaCell Therapeutics | 26.67M |
| IGC Pharma | 26.32M |
| Evaxion | 25.77M |
| Quantum BioPharma | 24.17M |
| Skye Bioscience | 23.89M |
| Longeveron | 22.29M |